Covidien plc (NYSE:COV) launched a voluntary recall of the entire production lot of its Duet TRS single-use heads for thoracic surgery after the company received reports of 13 serious injuries and 3 deaths following use.
"The company has concluded that Duet TRS has the potential to injure adjacent anatomical structures within the thorax, which may result in life-threatening, post-operative complications," according to a press release.